On June 3, 2020, Centers for Medicare & Medicaid Services (“CMS”) Administrator Seema Verma announced adjustments to the Center for Medicare and Medicaid Innovation (“CMMI”) models in light of the COVID-19 public health emergency.  Despite the accommodations being provided, Administrator Verma praised value-based incentives in a Health Affairs blog post, stating that “[t]hese models are even more important in a pandemic, to provide consistent, predictable income that keeps the focus on disease prevention.”  CMS  released a chart with the flexibilities relating to financial methodology changes, quality reporting changes, and model timeline changes for certain CMMI models.  Flexibilities are being provided for the following models:

  • Bundled Payments for Care Improvement Advanced
  • Comprehensive ESRD Care Model
  • Comprehensive Care for Joint Replacement Model
  • Direct Contracting (Global and Professional)
  • Emergency Triage, Treat, and Transport
  • Home Health Value-Based Purchasing Model
  • Independence at Home
  • Integrated Care for Kids Model
  • Kidney Care Choices
  • Maternal Opioid Misuse Model
  • Medicare Care Choices Model
  • Medicare Diabetes Prevention Program Expanded Model
  • Medicare ACO Track 1+ Model
  • Next Generation ACO
  • Oncology Care Model
  • Primary Care First – Serious Illness Component

Norton Rose Fulbright attorneys will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19 public health crisis.